What the service includes
- Screen up to 40 single agents or 12 combinations (as a standard offering)
- Cytotoxicity determined by Promega CellTitreGlo 3D ®
- Expert bioinformatics analyses available as an optional add-in
There are no delays on our products or support as a result of COVID-19. If there is a way we can assist you, we are here to help - Contact us
For immediate assistance Contact Us
Consult with your dedicated project team to define project scope:
Cell panel screens using Promega CellTitreGlo 3D®
Read about the benefits of using 3D systems to mimic tumor microenvironments -
'High-Throughput Cell Panel and Organoid Screening in 3D'
High-throughput screening in colorectal organoids - proof of concept study.
Demonstrating Horizon’s capability to screen organoids with compounds, either as single agent or in combination.
Benefit from our resources and 10 years experience.
Get in touch with our dedicated team today!